Jennison Associates’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-91,648
| Closed | -$1.23M | – | 680 |
|
|
2019
Q3 | $1.23M | Sell |
91,648
-10,265
| -10% | -$138K | ﹤0.01% | 522 |
|
|
2019
Q2 | $1.47M | Sell |
101,913
-100
| -0.1% | -$1.44K | ﹤0.01% | 515 |
|
|
2019
Q1 | $3.83M | Buy |
102,013
+88,404
| +650% | +$3.32M | ﹤0.01% | 475 |
|
|
2018
Q4 | $229K | Sell |
13,609
-1,576
| -10% | -$26.5K | ﹤0.01% | 635 |
|
|
2018
Q3 | $835K | Buy |
15,185
+120
| +0.8% | +$6.6K | ﹤0.01% | 565 |
|
|
2018
Q2 | $1.63M | Buy |
15,065
+190
| +1% | +$20.6K | ﹤0.01% | 541 |
|
|
2018
Q1 | $2.42M | Buy |
14,875
+2,263
| +18% | +$368K | ﹤0.01% | 501 |
|
|
2017
Q4 | $2.66M | Buy |
12,612
+145
| +1% | +$30.6K | ﹤0.01% | 515 |
|
|
2017
Q3 | $3.34M | Sell |
12,467
-33
| -0.3% | -$8.83K | ﹤0.01% | 510 |
|
|
2017
Q2 | $2.79M | Buy |
+12,500
| New | +$2.79M | ﹤0.01% | 519 |
|